Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism opn1mw2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism cacna1da expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism opn1sw2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
optic tectum neuronal action potential magnitude, ameliorated
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 1 ,
Fig. 3
from Whyte-Fagundes et al., 2022
|
whole organism slc6a3 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 6
from Safarian et al., 2020
|
locomotion increased occurrence, ameliorated
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism egr2a expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism gucy2d expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism opn1mw1 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism trpm6 expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism adora1b expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism ATP decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
whole organism opn1sw1 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism opn4.1 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism fosab expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
amacrine cell th2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 6
from Safarian et al., 2020
|
whole organism egr4 expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism grk7b expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
visual behavior process quality, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 5
from Safarian et al., 2020
|
whole organism th2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 6
from Safarian et al., 2020
|
whole organism egr2b expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism bdnf expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism p2rx1 expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
optic tectum action potential process quality, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: probenecid
|
Fig. 8
from Safarian et al., 2020
|
whole organism kcna2b expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
optic tectum action potential process quality, abnormal
|
panx1ayku1/yku1
|
lighting conditions
|
Fig. 8
from Safarian et al., 2020
|
whole organism guca1c expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism egr1 expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism ATP decreased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
whole organism slc18a2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 6
from Safarian et al., 2020
|
whole organism opn1lw2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism trpv4 expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism pde6ha expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism kcnc1a expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism gnat1 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
horizontal cell panx1a expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Figure 2
from Safarian et al., 2020
|
whole organism p2rx7 expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism pde6c expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism kcnc1b expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism jun expression increased amount, abnormal
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism gnat2 expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism gna11b expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
visual behavior process quality, ameliorated
|
panx1ayku1/yku1
|
lighting conditions, chemical treatment by environment: haloperidol
|
Fig. 7
from Safarian et al., 2020
|
whole organism kcnh4a expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism viability, ameliorated
|
panx1ayku1/yku1
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
swimming behavior process quality, abnormal
|
panx1ayku1/yku1
|
constant dark
|
Fig. 4
from Safarian et al., 2020
|
regulation of dopamine receptor signaling pathway process quality, abnormal
|
panx1ayku1/yku1
|
lighting conditions
|
Fig. 7
from Safarian et al., 2020
|
whole organism p2rx5 expression decreased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism rho expression increased amount, abnormal
|
panx1ayku1/yku1
|
standard conditions
|
Fig. 3
from Safarian et al., 2020
|
whole organism egr2a expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism fosab expression amount, ameliorated
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism egr1 expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism bdnf expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism ATP normal amount, ameliorated
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
optic tectum neuronal action potential magnitude, ameliorated
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 1 ,
Fig. 3
from Whyte-Fagundes et al., 2022
|
whole organism slc8a2b expression decreased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
whole organism egr2b expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism ATP increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
standard conditions
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
whole organism egr4 expression amount, ameliorated
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
locomotion increased occurrence, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|
whole organism entpd1 expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 7
from Whyte-Fagundes et al., 2022
|
whole organism jun expression increased amount, abnormal
|
panx1ayku1/yku1; panx1byku2/yku2
|
chemical treatment by environment: pentetrazol
|
Fig. 4
from Whyte-Fagundes et al., 2022
|